These findings indicate that ATF3 regulates inflammation and bone resorption via STAT3 and ERK signaling, reinforcing its potential as a therapeutic target for oral aging-related diseases, such as chronic periodontitis. This evidence concerns the gene ATF3 and periodontitis.